Freshpet, Inc. (FRPT) Q2 2025 Earnings Call Transcript

Freshpet reported Q2 2025 net sales up 12.5% to $264.7 million, slightly below expectations due to order timing, but achieved robust adjusted EBITDA growth of 26% to $44.4 million, driven by improved gross margins. Despite a subdued dog food market, the company maintained its full-year 2025 adjusted EBITDA guidance of $190-210 million while lowering its net sales growth outlook to 13-16%, citing significant operational efficiencies, including the Ennis plant's profitability and new production technologies. These improvements enabled a substantial $100 million reduction in CapEx for 2025-2026, and Freshpet reiterated its long-term margin targets of 48% adjusted gross margin and 22% adjusted EBITDA margin by 2027, even as it removed prior sales and household penetration targets, expecting continued market share gains through strategic marketing and distribution expansion.

Analysis

Freshpet's Q2 2025 results present a dual narrative of macroeconomic top-line pressure contrasted by significant operational outperformance. Net sales growth of 12.5% to $264.7 million, while strong, fell short of expectations and prompted a reduction in full-year 2025 sales growth guidance to 13-16% from 15-18%. Management attributes this slowdown to a subdued dog food market, citing consumer hesitation to trade up and a lower rate of new pet adoptions. Consequently, the company has formally withdrawn its ambitious $1.8 billion net sales target for 2027, acknowledging a more challenging growth trajectory. However, the underlying financial health appears robust, evidenced by a 26% year-over-year increase in adjusted EBITDA to $44.4 million and a 100-basis-point expansion in adjusted gross margin to 46.9%. This bottom-line strength, driven by superior yields and cost controls at its now most-profitable Ennis facility, allowed the company to reiterate its full-year adjusted EBITDA guidance of $190-$210 million. Critically, these operational efficiencies, coupled with new production technologies, have enabled a substantial reduction in capital intensity, with planned 2025-2026 CapEx cut by at least $100 million. This pivot underscores a strategic shift towards prioritizing profitability and cash generation, with the company maintaining confidence in reaching its 22% adjusted EBITDA margin target by 2027, contingent on maintaining sales growth in the teens.

Key Decisions for Investors

• Investors should recalibrate growth models to reflect the lower 13-16% sales guidance and the removal of the 2027 sales target, while recognizing the company's demonstrated ability to preserve and grow profitability through operational leverage.
• The significant $100 million reduction in 2025-2026 capital expenditures materially de-risks the financial profile and accelerates the path to positive free cash flow in 2026, a key catalyst that could attract investors focused on profitability and capital efficiency.
• Monitor the performance of the expanded club channel test and the impact of the new marketing campaign in the second half, as these are the primary drivers intended to stabilize top-line growth in the face of category headwinds.
• While competitive entry from brands like Blue Buffalo is a risk, management's view that it will expand the category is a key thesis point; investors should track Freshpet's dominant market share to validate its competitive moat and scale advantages.